2/12
08:00 am
acst
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
Medium
Report
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
2/7
09:37 am
acst
Acasti Pharma Inc. (NASDAQ: ACST) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $6.00 price target on the stock.
Low
Report
Acasti Pharma Inc. (NASDAQ: ACST) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $6.00 price target on the stock.
2/1
08:16 am
acst
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial [Yahoo! Finance]
Medium
Report
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial [Yahoo! Finance]
2/1
08:00 am
acst
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial
Medium
Report
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial